GSK Consumer Health, Inc. is recalling approximately 431,614 cartons of Theraflu Cough Relief (dextromethorphan HBr and guaifenesin) because the packaging is missing a required warning label. The label fails to instruct consumers to ask a doctor before use if they are on a sodium-restricted diet. This recall affects 6-packet cartons distributed nationwide in the United States. Consumers should check their medicine cabinets for the specific lot numbers and expiration dates listed below.
The product lacks a mandatory warning for individuals on sodium-restricted diets, which could lead to excessive sodium intake. This poses a potential health risk to consumers with conditions such as hypertension or kidney disease who must carefully manage their sodium levels.
Full refund available for affected products.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.